HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019.
Editor: Washington : U.S. Government Publishing Office, 2019Descripción: 1 online resource (iii, 63 pages)Tipo de contenido:- Human Immunodeficiency Virus prevention drug
- Billions in corporate profits after millions in taxpayer investments
- Gilead Sciences (Firm)
- Pre-exposure prophylaxis -- Prices -- United States
- Pre-exposure prophylaxis -- United States -- Cost control
- HIV infections -- United States -- Prevention
- Prescription pricing -- Government policy -- United States
- Pharmaceutical industry -- Prices -- Government policy -- United States
- Medical policy -- United States
- Federal aid to medical research -- United States
- KF27 .O96 2019i
Recursos en línea:
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurso en Internet | Biblioteca de Derecho Mons. Fremiot Torres Oliver Online | Y 4.OV 2:116-24 (Navegar estantería(Abre debajo)) | 1 | Disponible | Y 4.OV 2:116-24 |
Total de reservas: 0
"Serial no. 116-24."
CRDP Program record.
Description based on online resource; title from PDF title page (govinfo, viewed Aug. 12, 2019).